HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acid Violet 43 deemed safe with qualifications that meet FDA D&C Violet #2 criteria.

This article was originally published in The Rose Sheet

Executive Summary

CIR DEEMS ACID VIOLET 43 SAFE WITH QUALIFICATIONS that meet the specifications delineated by FDA for a similar chemical, the certified color additive D&C Violet #2. Of particular concern to the expert panel was the presence of p-toluidine in Acid Violet 43 in amounts greater than .1%, which is addressed by FDA for D&C Violet #2 certification. Donald Belsito, MD, University of Kansas Medical Center, who headed the review on Acid Violet 43, noted that "since we know that p-toluidine can create problems, I would move that we rule that Acid Violet 43 is safe for use as a hair colorant as long as it meets specifications of the external D&C Violet #2." FDA's safety criteria for the certified color additive limit the concentration of p-toluidine, a potential carcinogen, to no more than .1%. The Cosmetic Ingredient Review Expert Panel issued a tentative report for Acid Violet 43 at its meeting in Washington, D.C. March 20.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005251

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel